Recombinant celo virus and celo virus DNA

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C424S184100, C424S199100, C424S202100, C435S069100, C435S235100, C536S023720

Reexamination Certificate

active

06841158

ABSTRACT:
Recombinant CELO virus or CELO virus DNA with a deletion at the right end of the viral genome that allows insertion of large pieces of foreign DNA. The virus is useful as a vaccine for animals, in particular birds, and for gene therapy and vaccine applications in humans. The virus can also be used for recombinant protein production.

REFERENCES:
patent: 4491589 (1985-01-01), Dell et al.
patent: 6335016 (2002-01-01), Baker et al.
patent: 1490962 (1987-06-01), None
patent: WO 9740180 (1997-10-01), None
Michou et al. (Journal of Virology. 1999; 73 (2): 1399-1410.*
Nishiaka et al, Journal of Surigcal Research, vol. 38, pg. 592-598, 1985 (AG).*
Seidal et al, American Journal of Physiol., vol. 249, pg. G-434-38, 1985.*
Baker, A., et al., “Polyethylenimine (PEI) is a simple, inexpensive and effective reagent for condensing and linking plasmid DNA to adneovirus for gene delivery,”Gene Ther. 4:773-782 (Aug. 1997).*
Bett, A.J., et al., “An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3,”Proc. Natl. Acad. Sci. USA 91:8802-8806 (Sep. 1994).*
Boussif, O., et al., “A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: Polyethylenimine,”Proc. Natl. Acad. Sci. USA 92:7297-7310 (Aug. 1995).*
Buge, S.L., et al., “An Adenovirus-Simian Immunodeficiency Virus env Vaccine Elicits Humoral, Cellular, and Mucosal Immune Responses in Rhesus Macaques and Decreases Viral Burden following Vaginal Challenge,”J. Virol. 71:8531-8541 (Nov. 1997).
Caravokyri, C., and Leppard, K.N., “Constitutive Episomal Expression of Polypeptide IX (pIX) in a 293-Based Cell Line Complements the Deficiency of pIX Mutant Adenovirus type 5,”J. Virol. 69:6627-6633 (Nov. 1995).
Celli, G., et al., “Soluble dominant-negative receptor uncovers essential roles for fibroblast growth factors in multi-organ induction and patterning,”EMBO J. 17:1642-1655 (Mar. 1998).
Chartier, C., et al., “Efficient Generation of Recombinant Adenovirus Vectors by Homologous Recombination inEscherichia coli,” J. Virol. 70:4805-4810 (Jul. 1996).
Chiocca, S., et al., “The Complete DNA Sequence and Genomic Organization of the Avian Adenovirus CELO,”J. Virol. 70:2939-2949 (May 1996).
Chiocca, S., et al., “Identification of a Novel Antiaopototic Protein, GAM-1, Encoded by the CELO Adenovirs,”J. Virol. 71:3168-3177 (Apr. 1997).
Colby, W.W., and Shenk, T., “Adenovirus Type 5 Virions Can be Assembled In Vivo in the Absence of Detectable Polypeptide IX,”J. Virol. 39:977-980 (Sep. 1981).
Cotten, M., et al., “Chicken Adenovirus (CELO Virus) Particles Augument Receptor-Mediated DNA Delivery to Mammalian Cells and Yield Exceptional Levels of Stable Transformants,”J. Virol. 67:3777-3785 (Jul. 1993).
Cowen, B., et al., “Avian Adenoviruses: Effect on Egg Production, Shell Quality, and Feed Consumption,”Avian Diseases 22:459-470 (Jul.-Sep. 1978).
Crouzet, J., et al., “Recombinational construction inEscherichia coliof infectious adenoviral genomes,”Proc. Natl. Acad. Sci. USA 94:1414-1419 (Feb. 1997).
DeGregori, J., et al., “Distinct roles for E2F proteins in cell growth control and apoptosis,”Proc. Natl. Acad. Sci. USA 94:7245-7250 (Jul. 1997).
Degryse, E., “In vivo intermolecular recombination inEscherichia coli:application to plasmid constructions,”Gene 170:45-50 (Apr. 1996).
de Wet, J.R., et al., “Firefly Luciferase Gene: Structure and Expression in Mammalian Cells,”Mol. Cell. Biol. 7:725-737 (Feb. 1987).
Fisher, K. J., et al., “Recombinant Adenovirus Deleted of All Viral Genes for Gene Therapy of Cystic Fibrosis,”Virol. 217:11-22 (Mar. 1996).
Gerber, H.-P., et al., “VEGF is required for growth and survival in neonatal mice,”Develop. 126:1149-1159 (Mar. 1999).
Gerdts, V., et al., “Protection of Pigs against Aujeszky's disease by DNA vaccination,”J. Gen. Virol. 78:2139-2146 (Sep. 1997).
Ghosh-Choudhury, G., et al., “Protein IX, a minor component of the human adenovirus capsid, is essential for the packaging of full length genomes,”EMBO J. 6:1733-1739 (Jun. 1987).
Gluzman, Y., et al., “Helper-free Adenovirus Type-5 Vectors,” inEukaryotic Viral Vectors,Gluzman, Y., ed., Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, pp. 187-192 (1982).
Graham, F.L., and Smiley, J., “Characteristics of a Human Cell Line Transformed by DNA from Human Adenovirus Type 5,”J. Gen. Virol. 36:59-72 (Jul. 1977).
Grubb, B.R., et al., “Inefficient gene transfer by adenovirus vector to cystic fibrosis airway epithelia of mice and humans,”Nature 371:802-806 (Oct. 1994).
Hardy, S., et al., “Construction of Adenovirus Vectors through Cre-lox Recombination,”J. Virol. 71:1842-1849 (Mar. 1997).
Havenga, M.J. E., et al., “Second gene expression in bicistronic constructs using short synthetic intercistrons and viral IRES sequences,”Gene 222:319-327 (Nov. 1998).
Hay, R.T., et al., “Replication of Adenovirus Mini-chromosomes,”J. Mol. Biol. 175:493-510 (Jun. 1984).
He, T.-C., et al., “A simplified system for generating recombinant adenoviruses,”Proc. Natl. Acad. Sci. USA 95:2509-2514 (Mar. 1998).
Hess, M., et al., “The Avian Adenovirus Penton: Two Fibres and One Base,”J. Mol. Biol. 252:379-385 (Sep. 1995).
Horwitz, M.S., “Adenoviruses,” inFields Virology,Third Edition, Fields, B.N., et al., eds., Lippincott-Raven Publishers, Philadelphia, PA, pp. 2149-2171 (1996).
Imler, J.-L., et al., “An efficient procedure to select and recover recombinant adenovirus vectors,”Gene Ther. 2:263-268 (Jun. 1995).
Kawaguchi, T., et al., “Establishment and Characterization of a Chicken Hepatocellular Carcinoma Cell Line, LMH,”Cancer Res. 47:4460-4464 (Aug. 1987).
Karlsson, S., et al., “Transfer of genes into hematopoietic cells using recombinant DNA viruses,”Proc. Natl. Acad. Sci. USA 82:158-162 (Jan. 1985).
Khatri, A., et al., “Gene Expression by Atypical Recombinant Ovine Adenovirus Vectors during Abortive Infection of Human and Animal Cells in Vitro,”Virol. 239:226-237 (Dec. 1997).
Klonjkowski, B., et al., “A Recombinant E1-Deleted Canine Adenoviral Vector Capable of Transduction and Expression of a Transgene in Human-Derived Cells and In Vivo,”Human Gene Ther. 8:2103-2115 (Nov. 1997).
Kovesdi, I., et al., “Adenoviral vectors for gene transfer,”Curr. Opin. Biotechnol. 8:583-589 (Oct. 1997).
Kumar-Singh, R., and Chamberlain, J.S., “Encapsidated adenovirus minichromosomes allow delivery and expression of a 14 kb dystrophin cDNA to muscle cells,”Human Mol. Genet. 5:913-921 (Jul. 1996).
Lasher, H.N., and Davis, V.S., “History of Infectious Bursal Disease in the U.S.A.-The First Two Decades,”Avian Diseases 41:11-19 (Jan.-Mar. 1997).
Laver, W.G., et al., “Purification and Properties of Chick Embryo Lethal Orphan Virus (an Avian Adenovirus),”Virol. 45:598-614 (Sep. 1971).
Lemay, P., et al., “Human Adenovirus Type 2 Protein IIIa,”Virol. 101:131-143 (Feb. 1980).
Levenson, V.V., et al., “Internal Ribosomal Entry Site-Containing Retroviral Vectors with Green Fluorescent Protein and Drug Resistance Markers,”Human Gene Ther. 9:1233-1236 (May 1998).
Li, P., et al., “The Structural Proteins of Chick Embryo Lethal Orphan Virus (Fowl Adenovirus type 1),”J. Gen. Virol. 65:1803-1815 (Oct. 1984).
Li, P., et al., “DNA-binding Proteins of Chick Embryo Lethal Orphan Virus: Lack of Complementation between Early Proteins of Avian and Human Adenoviruses,”J. Gen. Virol. 65:1817-1825 (Oct. 1984).
Li, P., et al., “Structural Organization and Polypeptide Composition of the Avian Adenovirus Core,”J. Virol. 52:638-649 (Nov. 1984).
Li, X., et al., 

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Recombinant celo virus and celo virus DNA does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Recombinant celo virus and celo virus DNA, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant celo virus and celo virus DNA will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3428058

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.